Discovering ANSTO
The Australian Nuclear Science and Technology Organisation ( ANSTO ) is the centre of Australia's nuclear science capabilites and expertise. The organisation is one of the nation's unique and most valued scientific assets.
ANSTO produces radiopharmaceuticals to help in the diagnosis and treatment of a range of serious illnesses. We also help solve a wide range of industrial and environmental problems.
OPAL reactor
ANSTO's ability to deliver these solutions is made easier by our international reputation for undertaking outstanding, innovative scientific research.
The OPAL reactor was officially opened on 20 April 2007.
A further significant strategic activity ANSTO undertakes is providing impartial advice to government on a range of important long-term issues, including climate change, power generation and counter-terrorism.
ANSTO is on the edge of a new era, one in which our nation's prosperity and the well being of its citizens are linked to our ability to compete technologically on the world stage. By funding a new research reactor - OPAL- the Australian federal government has taken an important step towards securing Australia's future in an age of increasingly sophisticated industrial and medical technologies.
The OPAL research reactor will make it possible for ANSTO to deliver an extensive range of radioisotope products and industrial services to Australian and overseas customers.
OPAL will enhance our research capabilities, increase the range of world-class research programs we undertake and attract the best researchers from around Australia and throughout the world to collaborate with us.
One exciting area we anticipate becoming world leader in is neutron scattering science. This discipline is set to provide insight into some essential biological processes of the human body..